All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Signal Transducer and Activator of Transcription 3 Signaling in Tumor Immune Evasion

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216305%3A26620%2F22%3APU144087" target="_blank" >RIV/00216305:26620/22:PU144087 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.1016/j.pharmthera.2021.107969" target="_blank" >https://doi.org/10.1016/j.pharmthera.2021.107969</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.pharmthera.2021.107969" target="_blank" >10.1016/j.pharmthera.2021.107969</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Signal Transducer and Activator of Transcription 3 Signaling in Tumor Immune Evasion

  • Original language description

    The underlying mechanism of tumor immune evasion is a highly concerning subject for researchers. Increasing evidences reveal that the over-activated signal transducer and activator of transcription 3 (STAT3) is a crucial molecular hub in malignant tumors. STAT3 controls autophagy molecules that impair CTL-mediated tumor cell lysis, inhibiting natural killer cells and inducing apoptosis in T lymphocytes to create an immunosuppressive environment. STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to establish a tolerant tumor microenvironment (TME). STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to create an immunosuppressive environment. All this aid tumor cells in escaping from immune surveillance. In this review, we outlined the STAT3-mediated mechanisms involved in tumor immune evasion and their potential regulatory functions in the TME. We discussed the impact of STAT3 signaling on PD-L1, HIF-1α, exosome, lncRNA, and autophagy in the promotion of tumor immune evasion and highlighted the recent research on STAT3 signaling and tumor immune evasion that may assist in developing effective STAT3-targeted drugs for advancing immunotherapy.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

  • OECD FORD branch

    30104 - Pharmacology and pharmacy

Result continuities

  • Project

  • Continuities

    R - Projekt Ramcoveho programu EK

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    PHARMACOLOGY & THERAPEUTICS

  • ISSN

    0163-7258

  • e-ISSN

  • Volume of the periodical

    230

  • Issue of the periodical within the volume

    107969

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    11

  • Pages from-to

    1-11

  • UT code for WoS article

  • EID of the result in the Scopus database

    2-s2.0-85114008413